New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 16, 2014
09:12 EDTCSX, ILMN, BLK, SCHW, C, UNH, SRPT, APO, YHOO, HPQ, AMRN, AMGN, NUS, CEC, JCP, BBYOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Charles Schwab (SCHW), up 3%... BlackRock (BLK), up 1.5%. ALSO HIGHER: CEC Entertainment (CEC), up 13% after acquired by Apollo (APO) affiliate for $54 per share... HP (HPQ), up 2% after upgraded at BofA Merrill Lynch... Sarepta Therapeutics (SRPT), up 16% after announcing that data from a study of eteplirsen demonstrates continued stability in walking test... Illumina (ILMN), up 4.8% after in agreement with Amgen (AMGN) to develop oncology companion diagnostic test. DOWN AFTER EARNINGS: Citigroup (C), down 2.6%... CSX (CSX), down 6%.... UnitedHealth (UNH), down 0.5%. ALSO LOWER: Best Buy (BBY), down 30% after reporting domestic Holiday same-store sales fell 0.9%... Yahoo (YHOO), down 2% after COO Henrique de Castro to leave company effective January 16 after reportedly clashing with CEO Mayer... J.C. Penney (JCP), down 3.9% after announcing plans to close 33 underperforming stores and cut 2K jobs... after reporting earnings and revenue that just slightly missed estimates... Nu Skin (NUS), down 16.3% after responding to People's Daily article that called it a "pyramid scheme"... Amarin (AMRN), down 9.6% after the FDA delayed its ANCHOR SPA appeal, shares downgraded at MKM Partners.
News For BBY;HPQ;C;JCP;YHOO;SCHW;CEC;APO;BLK;NUS;SRPT;ILMN;AMGN;UNH;CSX;AMRN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>
July 21, 2015
10:01 EDTNUSOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:56 EDTYHOOSalesforce rallies amid renewed speculation of Microsoft deal
Subscribe for More Information
07:52 EDTHPQHP announces renewable energy agreement with SunEdison
Subscribe for More Information
07:12 EDTAMGNAmgen's Repatha granted marketing authorization by EC
Amgen announced that the European Commission, or EC, has granted marketing authorization for Repatha, or evolocumab, the first proprotein convertase subtilisin/kexin type 9, or PCSK9, inhibitor to be approved in the world, for the treatment of patients with uncontrolled cholesterol who require additional intensive low-density lipoprotein cholesterol reduction. Repatha is a human monoclonal antibody that inhibits PCSK9, a protein that reduces the liver's ability to remove LDL-C, or "bad" cholesterol, from the blood.
06:57 EDTBLKBlackRock wins license to raise funds in China, Reuters reports
Subscribe for More Information
06:38 EDTYHOOYahoo volatility increases into Q2 and outlook
Subscribe for More Information
06:19 EDTHPQSilicon Valley giants side with Samsung in battle with Apple, InsideSources says
Subscribe for More Information
06:07 EDTYHOOONUG: Yahoo hires VP of global network from Symantec
Subscribe for More Information
05:50 EDTYHOOYahoo could drop below $38 on negative tax announcement, says Piper Jaffray
Subscribe for More Information
July 20, 2015
16:41 EDTNUSNu Skin initiated with a Neutral at Sterne Agee CRT
Subscribe for More Information
16:01 EDTCOptions Update; July 20, 2015
Subscribe for More Information
14:32 EDTSRPTFDA panel likely to review Sarepta, BioMarin drugs in November, TheStreet says
Subscribe for More Information
13:03 EDTCFed proposes final rule on capital surcharges for largest U.S. banks
Subscribe for More Information
12:20 EDTYHOOYahoo July weekly volatility increases into Q2 and outlook
Subscribe for More Information
11:03 EDTSRPTSarepta rises after Roth says added data can keep it ahead of BioMarin
Subscribe for More Information
10:13 EDTSRPTOptions with decreasing implied volatility
Subscribe for More Information
09:34 EDTBLKHalliburton sees significant runway for refrack in the future
Subscribe for More Information
09:31 EDTBBYBest Buy store rationalization to be catalyst, says BB&T
Subscribe for More Information
06:59 EDTYHOOYahoo says taxes could 'materially reduce' Aabaco cash for distributions
Subscribe for More Information
06:17 EDTILMNMizuho sees Q2 earnings beats in Diagnostics space
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use